相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Genetic Variation of Genes Involved in Dihydrotestosterone Metabolism and the Risk of Prostate Cancer
Sunita R. Setlur et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)
Reporting and managing elevated testosterone/epitestosterone ratios - Novel aspects after five years' experience
Ute Mareck et al.
DRUG TESTING AND ANALYSIS (2010)
Potentially harmful advantage to athletes: a putative connection between UGT2B17 gene deletion polymorphism and renal disorders with prolonged use of anabolic androgenic steroids
Nawed Deshmukh et al.
SUBSTANCE ABUSE TREATMENT PREVENTION AND POLICY (2010)
Steroid profiles of professional soccer players: an international comparative study
E. Strahm et al.
BRITISH JOURNAL OF SPORTS MEDICINE (2009)
UDP-Glucuronosyltransferases (UGTs) 2B7 and UGT2B17 Display Converse Specificity in Testosterone and Epitestosterone Glucuronidation, whereas UGT2A1 Conjugates Both Androgens Similarly
Taina Sten et al.
DRUG METABOLISM AND DISPOSITION (2009)
A Common Deletion in the Uridine Diphosphate Glucuronyltransferase (UGT) 2B17 Gene Is a Strong Determinant of Androgen Excretion in Healthy Pubertal Boys
A. Juul et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Substantial advantage of a combined Bayesian and genotyping approach in testosterone doping tests
Jenny Jakobsson Schulze et al.
STEROIDS (2009)
From population- to subject-based limits of T/E ratio to detect testosterone abuse in elite sports
Pierre-Edouard Sottas et al.
FORENSIC SCIENCE INTERNATIONAL (2008)
Doping test results dependent on genotype of uridine diphospho-glucuronosyl transferase 2B17, the major enzyme for testosterone glucuronidation
Jenny Jakobsson Schulze et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
The UGT2B17 gene deletion is not associated with prostate cancer risk
Mats Olsson et al.
PROSTATE (2008)
Deletion polymorphism of the UGT2B17 gene is associated with increased risk for prostate cancer and correlated to gene expression in the prostate
A-H Karypidis et al.
PHARMACOGENOMICS JOURNAL (2008)
Association between polymorphisms in HSD3B1 and UGT2B17 and prostate cancer risk
Jong Y. Park et al.
UROLOGY (2007)
The UGT2B17 gene deletion polymorphism and risk of prostate cancer - A case-control study in Caucasians
Carla J. Gallagher et al.
CANCER DETECTION AND PREVENTION (2007)
Deletion polymorphism of UDP-glucuronosyltransferase 2B17 and risk of prostate cancer in African American and Caucasian men
Jong Park et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2006)
Testosterone and doping control
C. Saudan et al.
BRITISH JOURNAL OF SPORTS MEDICINE (2006)
Large differences in testosterone excretion in Korean and Swedish men are strongly associated with a UDP-glucuronosyl transferase 2B17 polymorphism
J Jakobsson et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Characterization of a common deletion polymorphism of the UGT2B17 gene linked to UGT2B15
W Wilson et al.
GENOMICS (2004)
Glucuronidation of anabolic androgenic steroids by recombinant human UDP-glucuronosyltransferases
T Kuuranne et al.
DRUG METABOLISM AND DISPOSITION (2003)
Genetic polymorphisms of UDP-glucuronosyltransferases and their functional significance
JO Miners et al.
TOXICOLOGY (2002)
Relative enzymatic activity, protein stability, and tissue distribution of human steroid-metabolizing UGT2B subfamily members
D Turgeon et al.
ENDOCRINOLOGY (2001)
分享论文
